Abstract
Mouse protection tests were carried out with four antibiotics and six strains of Pseudomonas aeruginosa. All strains were susceptible to all four antibiotics by an in vitro test. A heavier bacterial inoculum increased the mean effective dose of gentamicin and tobramycin, but not polymyxin B. Second and third doses of gentamicin in the mouse protection test made little change in the mean effective dose. In the mouse protection tests, tobramycin was the most active antibiotic if the results were analyzed in terms of the therapeutic index or ratio of toxicity to efficacy. Colistimethate was poorly inactive in vivo. Polymyxin B was most active on an absolute basis but also was the most toxic. One strain of Pseudomonas was classified as resistant to gentamicin in vivo although it was susceptible in vitro. Strains of Pseudomonas that were uniformly susceptible to antibiotics in vitro were not uniformly susceptible in the mouse protection test to low doses of antibiotic.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Davis S. D. Dissociation between results of in vitro and in vivo antibiotic susceptibility tests for some strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1974 Mar;5(3):281–288. doi: 10.1128/aac.5.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis S. D., Iannetta A. Relative antagonism in vitro of calcium in serum to the bactericidal activities of gentamicin and tobramycin on Pseudomonas aeruginosa. Chemotherapy. 1973 Oct;19(4):243–253. doi: 10.1159/000221461. [DOI] [PubMed] [Google Scholar]
- Davis S. D., Iannetta A., Wedgwood R. J. Antibiotics for Pseudomonas aeruginosa sepis: inadequate proof of efficacy. J Infect Dis. 1971 Jul;124(1):104–106. doi: 10.1093/infdis/124.1.104. [DOI] [PubMed] [Google Scholar]
- Davis S. D. Letter: Interpretation of in vivo tests of susceptibility to antibiotics. J Infect Dis. 1973 Nov;128(5):672–673. doi: 10.1093/infdis/128.5.672. [DOI] [PubMed] [Google Scholar]
- Fisher M. W., Devlin H. B., Gnabasik F. J. New immunotype schema for Pseudomonas aeruginosa based on protective antigens. J Bacteriol. 1969 May;98(2):835–836. doi: 10.1128/jb.98.2.835-836.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heifetz C. L., Chodubski J. A., Pearson I. A., Silverman C. A., Fisher M. W. Butirosin compared with gentamicin in vitro and in vivo. Antimicrob Agents Chemother. 1974 Aug;6(2):124–135. doi: 10.1128/aac.6.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu P. V. Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A. J Infect Dis. 1973 Oct;128(4):506–513. doi: 10.1093/infdis/128.4.506. [DOI] [PubMed] [Google Scholar]
- Medeiros A. A., O'Brien T. F., Wacker W. E., Yulug N. F. Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin. J Infect Dis. 1971 Dec;124 (Suppl):S59–S64. doi: 10.1093/infdis/124.supplement_1.s59. [DOI] [PubMed] [Google Scholar]
- Reller L. B., Schoenknecht F. D., Kenny M. A., Sherris J. C. Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis. 1974 Nov;130(5):454–463. doi: 10.1093/infdis/130.5.454. [DOI] [PubMed] [Google Scholar]
- Waitz J. A., Moss E. L., Jr, Drube C. G., Weinstein M. J. Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin. Antimicrob Agents Chemother. 1972 Dec;2(6):431–437. doi: 10.1128/aac.2.6.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weinstein M. J., Drube C. G., Moss E. L., Jr, Waitz J. A. Microbiologic studies related to bacterial resistance to gentamicin. J Infect Dis. 1971 Dec;124 (Suppl):S11–S17. doi: 10.1093/infdis/124.supplement_1.s11. [DOI] [PubMed] [Google Scholar]